Risk Based CMC Review An Update
Risk Based CMC Review An Update . ACPS Meeting October 21, 2002 Yuan-yuan Chiu, Ph.D. Director, ONDC/OPS, FDA. Objectives. To compile a list of drugs (low risk with respect to quality) that will qualify for the elimination of most of NDA/ANDA manufacturing supplements
179 views • 6 slides